28 Sept 2026, 09:49
Company Update—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 28 Sept 2026, 09:49 | Completion of FDA Inspection of New Manufacturing Facility | Company Update | — | 11001, 12008 | |
| 24 Sept 2026, 11:13 | Upcoming Australian Investor Conferences | Company Administration | — | 12008 | |
| 22 Sept 2026, 16:13 | Substantial Holding Notification | Substantial Holders | — | 02006 | |
| 21 Sept 2026, 09:07 | CMS Finalises Increased Inpatient Reimbursement for WiSE | Company Update | MS | 11001 | |
| 16 Sept 2026, 08:37 | EBR FDA Plan for Addressing Echo-induced Pacing Risks | Company Update | — | 11001 | |
| 15 Sept 2026, 09:24 | FDA Initiates Inspection of New Manufacturing Facility | Company Update | — | 11001 | |
| 9 Sept 2026, 09:30 | Investor Roadshow | Presentations | — | 14014 | |
| 9 Sept 2026, 09:26 | Update on FDA Review of Cybersecurity Incident | Company Administration | — | 12008 | |
| 7 Sept 2026, 09:20 | New Manufacturing Facility Achieves ISO Certification | Company Update | MS | 11001 | |
| 25 Aug 2026, 11:25 | Cleansing Notice | Securities Administration | — | 06018 | |
| 25 Aug 2026, 11:20 | Application for quotation of securities - EBR | Securities Administration | — | 06020 | |
| 25 Aug 2026, 09:01 | Form S-8 Registration Statement | Securities Administration | — | 06009 | |
| 21 Aug 2026, 08:38 | Transition of Chief Commercial Officer | Company Administration | — | 12008 | |
| 19 Aug 2026, 12:50 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 12 Aug 2026, 08:25 | Q2 2026 Quarterly Activity Report and Form 10-Q Submission | Periodic Reports | MS | 03014, 19007 | |
| 4 Aug 2026, 09:09 | EBR to Attend Canaccord 46th Annual Growth Conference | Company Administration | — | 12008 | |
| 31 July 2026, 09:19 | Investor Webinar Presentation | Presentations | — | 03026 | |
| 31 July 2026, 09:11 | Additional Information Regarding Recent Reports | Company Update | MS | 11001, 14014 | |
| 30 July 2026, 09:46 | Q2 2026 Progress in WiSE Commercial Rollout | Company Update | MS | 11001, 12008, 14014 | |
| 29 July 2026, 09:36 | Investor Webinar | Presentations | — | 03027, 14014 | |
| 27 July 2026, 09:10 | Application for quotation of securities - EBR | Securities Administration | — | 06020 | |
| 24 July 2026, 14:35 | EBR Responds to Speculation | Other | — | 11004 | |
| 24 July 2026, 09:54 | Launch of WiSE Coupler Accessory for U.S. Commercial Use | Company Update | MS | 03027, 11001 | |
| 24 July 2026, 09:41 | Notification regarding unquoted securities - EBR | Securities Administration | — | 06021 | |
| 23 July 2026, 10:04 | Notification of cessation of securities - EBR | Securities Administration | — | 06027 | |
| 16 July 2026, 09:31 | Substantial Holding Notification | Substantial Holders | — | 02006 | |
| 10 July 2026, 09:24 | Notice of 2026 Special Meeting of Stockholders | Meetings & Governance | — | 08002, 08004 | |
| 6 July 2026, 09:35 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 30 June 2026, 09:00 | Change of Registered Address in Australia | Securities Administration | — | 12003 | |
| 30 June 2026, 08:55 | Special Meeting of Stockholders and Preliminary Proxy | Meetings & Governance | — | 08006 | |
| 29 June 2026, 10:25 | Application for quotation of securities - EBR | Securities Administration | — | 06020 | |
| 24 June 2026, 16:54 | Completion of Retail Entitlement Offer | Capital Raising | — | 06008 | |
| 18 June 2026, 11:05 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 June 2026, 09:50 | Cleansing Notice | Securities Administration | — | 06018 | |
| 11 June 2026, 11:40 | Notice of Dispatch of Retail Entitlement Offer Documents | Capital Raising | — | 06008 | |
| 11 June 2026, 09:59 | Retail Entitlement Offer Opens | Capital Raising | MS | 03026, 06008 | |
| 11 June 2026, 09:53 | Application for quotation of securities - EBR | Securities Administration | — | 06020 | |
| 11 June 2026, 09:08 | Form 8-K - Entry into a Material Definitive Agreement | Securities Administration | — | 06009 | |
| 5 June 2026, 09:25 | Successful Completion of Institutional Offer | Capital Raising | MS | 06003, 06008, 09014 | |
| 4 June 2026, 11:55 | Cleansing Notice | Securities Administration | — | 06018 | |
| 4 June 2026, 11:44 | Proposed issue of securities - EBR | Securities Administration | — | 06013 | |
| 4 June 2026, 11:44 | EBR Fundraising Presentation - June 2026 | Presentations | — | 03026 | |
| 4 June 2026, 11:41 | EBR to Raise A$150m via Fully Underwritten Capital Raising | Capital Raising | MS | 06003, 06008 | |
| 4 June 2026, 10:06 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 4 June 2026, 09:52 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 4 June 2026, 09:15 | CMS Initiates National Coverage Determination for WiSE | Company Update | MS | 11001 | |
| 20 May 2026, 09:19 | Purchasing Agreement Secured with CHRISTUS Health | Company Update | MS | 11001 | |
| 18 May 2026, 09:12 | Purchasing Agreement Secured with Advocate Health | Company Update | MS | 11001 | |
| 14 May 2026, 17:20 | Appendix 3Ys - Grant of Options | Director Interests | — | 02009 | |
| 14 May 2026, 16:58 | Notification regarding unquoted securities - EBR | Securities Administration | — | 06021 |